(JNS.org) The International Cannabinoid Research Society (ICRS) will hold its global conference at Israel’s Hebrew University of Jerusalem in 2021.
The ICRS—the oldest scientific society devoted to the study of cannabis—convenes annually and has some 400 members around the world.
Previous conferences by the group have focused on using cannabis-based medicines to treat autoimmune disorders, epilepsy, pain, PTSD, metabolism, obesity, cancer and other ailments.
The society’s 2021 International Symposium on the Cannabinoids in Jerusalem will host hundreds of Israeli and international participants at the Jerusalem International Convention Center.
Hebrew University’s Multidisciplinary Center on Cannabinoid Research will host the conference.
“[Israeli] Prof. Raphael Mechoulam was the first to publish the structure of the active principal of cannabis, THC, and was also the first to identify an endogenous cannabinoid, anandamide,” noted ICRS Executive Director Prof. Cecilia Hillard said, The Jerusalem Post reported.
“Just as impressive is the current state of cannabinoid research in Jerusalem and Israel at large, including the Multidisciplinary Center on Cannabinoid Research led by Dr. Joseph Tam. We are looking forward to visiting Jerusalem and to an exciting and informative conference,” she said.